LPTX - Leap Therapeutics GAAP EPS of -$0.13 misses by $0.01 November, 14 2022 08:09 AM Leap Therapeutics Inc. Leap Therapeutics press release ( NASDAQ: LPTX ): Q3 GAAP EPS of -$0.13 misses by $0.01 . Net Loss was $15.1 million for the third quarter 2022 For further details see: Leap Therapeutics GAAP EPS of -$0.13 misses by $0.01